The study of apoptotic cells by flow cytometry MG Ormerod 34 Wray Park Road, Reigate, RH2 ODE, UK Programmed cell death (PCD) is of fundamental importance in the normal development of an animal. It also plays a key role in tumour and radiation biology. PCD produces a sequence of changes occurring in cells called apoptosis. The main elements of this apoptotic cascade are rapidly being elucidated. Flow cytometry has been used to follow many of these changes. It has also been used to quantify the number of apoptotic cells in a culture and, more recently, in clinical samples. In this review, the properties of apoptotic cells and the main features of the apoptotic cascade are described. How flow cytometry can be used to follow changes during the apoptotic cascade is then discussed.
Introduction
During development of an animal, the removal of unwanted cells is of fundamental importance. This removal is often referred to as programmed cell death (PCD) and the process by which the cells are destroyed has been named apoptosis. 1 The importance of PCD is underlined by the conservation of key proteins through evolution; genes identified in a nematode have homologies in man. [2] [3] [4] PCD serves to (1) sculpt structures; (2) delete unneeded structures; (3) control cell numbers; (4) produce differentiated cells without organelles; and (5) eliminate abnormal, misplaced, nonfunctional or harmful cells. 5 It is an escape from the controls imposed by the latter process which probably allows malignant cells to arise. 6 Whether or not a cancer cell responds to DNA damage by triggering the apoptotic pathway could also be a determining factor in the response of a tumour to therapy.
A sequence of changes occurs in cells during the process of apoptosis, giving rise to an apoptotic cascade of events. It has been proposed that the proteins involved in PCD are expressed constitutively in all nucleated animal cells and that the activation of PCD, in development at least, may be controlled transcriptionally. 7 Flow cytometry has been used to follow some of these changes. It has also been used to quantify the number of apoptotic cells in a culture or, more recently, in a clinical sample. Both these aspects are discussed in this review.
The flow cytometer makes measurements on individual cells; typically, up to seven parameters might be measured on tens of thousands of cells in a few minutes. A biochemical measurement records an average reading in a piece of tissue or a collection of cells. A low reading might reflect a low expression across the entire population or might mask a high expression in a few cells, the majority of the population being negative. For example, gel electrophoresis of DNA from apopCorrespondence: MG Ormerod; email:Michael Ormerod@compu-serv.com Received 12 January 1998; accepted 10 February 1998 totic cells shows a typical 'ladder' pattern due to a specific pattern of DNA degradation (see below). The observation of such a ladder from the extracted DNA merely indicates the presence of apoptotic cells. However, if the strand breaks in intact, fixed cells are labelled enzymatically, a flow cytometer can be used to determine the percentage of apoptotic cells and, if required, these cells can be sorted for further study.
Moreover, tissues are heterogeneous in regard to the types of cell present and, even in cultured cells, there are heterogeneities present in, for example, position within the cell cycle. Using multiparameter image or flow cytometry, measurements can be made on selected cells so that heterogeneity can be taken into account; small subpopulations can also be studied. The advantage of the flow cytometer is that large numbers of cells can be processed giving a good statistical analysis of populations; the disadvantage is that a suspension of single cells is required, often a problem when studying solid tumours. Unlike image cytometry, the flow cytometer gives no information about the distribution of a product within a cell. However, as I will demonstrate, the advantages of flow cytometry are such that it has become an essential tool in the study of apoptosis.
In this review, I will describe the properties of apoptotic cells by which they are generally recognised, I will describe the main features of the apoptotic cascade, as far as they are known at present, and then discuss how the flow cytometer has been used in these studies.
Morphological changes in apoptotic cells
Apoptotic cells were first recognised by their morphological features 1 and morphology is still the only means of unequivocally identifying an apoptotic cell. Despite the wealth of literature, a unique biochemical characteristic of all apoptotic cells has yet to be identified.
The changes in morphology during apoptosis have been reviewed by Wyllie et al. 8 Apoptotic cells shrink and detach from their neighbours; in epithelial tissues, the desmosomal attachments break. Cultured cells growing as adherent monolayers often detach from the surface of the culture dish during apoptosis and are to be found floating in the culture medium. Blebbing of the plasma membrane is frequently observed. The chromatin undergoes characteristic changes. It condenses on to the nuclear membrane and, as apoptosis proceeds, the nucleus usually fragments, each fragment containing heavily condensed chromatin. Loss of integrity of the plasma membrane is a late event in apoptosis generally only observed in cell cultures and in association with necrotic centres in solid tumours. In vivo, apoptotic cells are engulfed by neighbouring cells or by macrophages while the plasma membrane is still intact.
During necrosis, the nuclear and plasma membrane rupture, mitchondria swell and the cells enlarge. In particular, the plasma membrane loses its integrity early in the process. As the nucleus swells, the chromatin loses its structure and appears amorphous (pyknotic). 8 A good example of the different morphologies of apoptotic and necrotic cells can be found in Lizard et al. 9 Some of the various morphological aspects of cell death have been discussed by Majno and Joris whose paper also includes a historical perspective. 10 It should be stressed that there are other mechanisms of cell death that differ from apoptosis and necrosis as described above (for example, see Ref. 11) . Apoptosis and necrosis may also share some common biochemical pathways and the response to a given type of injury with regard to apoptosis or necrosis may depend on factors such as the ATP levels in the cell. 12 The cells in Figure 1 show typical apoptotic morphology. They have shrunk, the heterochromatin has condensed on to the nuclear membrane, and the nucleoli are swollen. If the chromatin of such cells is stained by a fluorescent dye, such as acridine orange or Hoechst 33342, changes in the chroma- tin can by observed by fluorescence microscopy. 13, 14 Phase contrast microscopy or electronic sizing in a Coulter counter can be used to observe cell shrinkage. 15, 16 Microscopic observation should always be used to confirm the presence of apoptotic cells.
Changes in the chromatin are accompanied by the introduction of strand breaks into the chromosomal DNA. Degradation into 30-50 kbp fragments (probably preceded by breaks at 700 and 300 kbp intervals) is an important early event in apoptosis. 17 It has been postulated that an endonuclease cuts the DNA between chromatin domains (or loops). 18 The process seems to go rapidly to completion since the bulk of the DNA can be found in a single band on pulse field gel electrophoresis (in contrast to the internucleosomal degradation, see below).
At a later stage in apoptosis, there is further degradation of the DNA at the internucleosomal linkers. 19 The cleavage is incomplete and appears to be random since a series of fragments are produced which are multiples of the basic unit of about 200 bp. On DNA gel electrophoresis, this pattern of degradation gives a characteristic DNA 'ladder'. It has been suggested that internucleosomal degradation is the biochemical hallmark of apoptosis. However, morphological changes characteristic of apoptosis together with degradation of the DNA into 30-50 kbp fragments has been observed in the absence of DNA 'ladders'. 20, 21 Alterations in the nuclear chromatin and its DNA are the most striking features of the apoptotic cell. Understandably, early biochemical work tended to concentrate on these changes. However, cytoplasmic changes associated with apoptosis have been observed in the absence of a nucleus 7, 22 and it is now apparent that a series of cytoplasmic events precede those in the nucleus.
The apoptotic cascade
There is intense research in this field and anything written is likely to be out of date by the time it is published. Furthermore, in mammalian cells, important processes, such as those governing cell proliferation and death, are usually controlled by several alternative pathways. I have not detailed all the alternatives (where they have been defined) but have attempted to select the main themes; several recent reviews have described some of the major elements. 5, [23] [24] [25] [26] [27] [28] [29] [30] [31] There are two key elements in the apoptotic cascade located in the cytoplasm. One is the mitochondrion. 32 The other involves a series of cysteine proteases, 28, 33 one of which is interleukin-1␤ converting enzyme (ICE). The other proteases were originally described as ICE-like but the whole family have now been named caspases (cysteine aspartate-specific proteases). 28, 34 Their genes are homologous to ced-3 identified as one of the genes in the death programme of the nematode, Caenorhabditis elegans. 2 The caspases exist in the cytoplasm as inactive proenzymes. Once the process has been initiated, pro-caspases are activated by cleavage by other caspases in a cascade. 25, 27 The caspases function as executors of the apoptotic process but can also be involved in its initiation. They act on a variety of other substrates that are probably crucial to the morphological changes observed during apoptosis (see below).
PCD can be triggered by a signal on the plasma membrane (for example, by the interaction of FAS ligand, FASL, with the FAS receptor 35 ) or by the lack of an appropriate signal. 36 It has been postulated that all cells are primed to undergo PCD but that the death programme is held in check by positive signals arising, for example, from the correct cell contacts. 37 Many of the steps leading to the induction of PCD resulting from activation of FAS (also called CD95 and APO-1) have been elucidated 27 and this system is a good model for following the general process.
FAS is a transmembrane protein which is a member of the tumour necrosis factor (TNF) receptor family. 38 Extracellular binding of FASL induces trimerisation of FAS and the binding on the intracellular face of the plasma membrane of FASassociating protein with death domain (FADD, also called MORT1). The death domain binds a cysteine protease, caspase 8, also known as FLICE (FADD-like ICE) or MACH (Mort-1 associated ced3 homologue). In this state, pro-caspase-8 probably self-cleaves to give an active enzyme that initiates the capsase cascade. 27 The interaction of TNF with its cell surface receptor initiates a similar sequence of events. The trimerised TNFR1 recruits TNFR1-associated death domain protein (TRADD) which in turn binds FADD. There are two alternative pathways; one also leads to apoptosis and involves interaction with a serine/threonine kinase, receptor interacting protein (RIP); the other pathway enhances cell survival. 27 It has recently been shown that apoptosis initiated by the oncogene, c-myc, requires interaction of FAS and its ligand at the cell surface. 39 The gene product, c-Myc, a transcription factor, sensitises the cells to FAS-mediated apoptosis by an unknown mechanism. The protein, p53 plays an important role in determining whether a cell responds to DNA damage by committing apoptosis. 29 The crucial links with the caspases in the cytoplasm have still to be identified but it has been shown that p53 can upregulate FAS 40 and downregulate the expression of the receptor for the growth factor, IGF-1. 41 The caspase cascade is regulated by the bcl-2 family of proteins located on the mitochondrial membrane 30 (bcl-2 is also found on other sites, including the endoplasmic reticulum and the nuclear membrane). These proteins contain members that block the apoptotic process and others which drive it; 42 they dimerise with one another and the balance between the classes of the bcl-2 family will determine whether a cell is susceptible to the induction of apoptosis or not. There is strong evidence that the link between the bcl-2 family of proteins (on the mitochondrial membrane) and the caspase cascade is mediated by a mammalian homologue of the C. elegans gene, ced-4. 24, 31, [43] [44] [45] A candidate protein has recently been identified and named apoptosis activating factor-1 (Apaf-1). 44 Cytochrome-c (released from mitochondria, see below) and the caspase-9 zymogen both bind to Apaf-1, thereby activating caspase-9 46 which in turn activates caspase-3 and/or caspase-4. 45 The control exercised by bcl-2 probably acts in the early stages of the cascade since the reduction of the inner mitochondrial membrane potential (MMP) appears to be downstream of the initiation of the caspase cascade 47 while overexpression of bcl-2 blocks the action of caspase-4 and caspase-3. [48] [49] [50] Apoptosis can be blocked by bongkrekic acid, a compound that prevents the opening of pores in the mitochondrial membrane, indicating that progression of the cascade requires the reduction in MMP. 51 During apoptosis, mitochondria release proteins, such as cytochrome-c and apoptosis-inducing factor (AIF), which are probably needed for the continuation of the caspase cascade. 47, [52] [53] [54] Overexpression of bcl-2 blocks the release of AIF. 54 It has been proposed that cytochrome-c release precedes the breakdown in inner mitochondrial membrane potential. 55 It is not clear how the initial caspase activation induces a breakdown of the MMP. The tertiary structure of the bcl-xL suggests that these proteins can generate pores in membranes. 56, 57 One can speculate that cleavage of a key peptide (located on the mammalian ced-4 homologue?) allows dimers of the appropriate members of the bcl-2 family (bax, bcl-x S , etc) to open pores in the mitochondrial membrane and that dimers of bcl-2 and bcl-x L do not respond in this fashion, so that overexpression of these proteins blocks this process.
Caspases act on caspases; they also have a variety of other substrates, including nuclear proteins, such as poly(ADPribose) polymerase and DNA-dependent protein kinase, U1 ribonucleoprotein and the nuclear lamins, and components of the cytoskeleton such as actin. 25, 33 While it is not yet known how the action of these proteases causes the morphological changes observed in apoptotic cells, destruction of structural proteins is likely to induce cell shrinkage and other changes in the plasma membrane. Similarly degradation of nuclear proteins, including lamin, could cause alterations in chromatin structure. Caspase-3 can cleave and activate the 45 kDa subunit of a protein, named DNA fragmentation factor, which leads to the degradation of DNA into nucleosomal fragments. 58 The outline of the apoptotic cascade described above is summarised in Figure 2 . There is evidence to suggest that there may be an alternative, FAS-mediated, apoptotic pathway that may by-pass some of the steps outlined in the Figure. 
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Figure 2
Summary of the main events following initiation of apoptosis, illustrating the central role of the mitochondria.
Figure 3
Correlated expression of bcl-2 and bax. Peripheral blood lymphocytes from a patient with chronic lymphocytic leukaemia (CLL) stained for bcl-2, bax and CD19 (pan B-cell marker) Separated peripheral blood lymphocytes were first stained with antiCD19 conjugated to PE-Cy5. After fixing and permeabilising the cells were incubated with either anti-bcl-2 FITC and anti-bax or with isotype control Igs. Finally they were incubated with a PE-labelled antiımouse Ig. cytometer include bcl-2, bax, c-myc, p53 60, [62] [63] [64] [65] [66] [67] [68] and phosphotyrosine. 69 Flow cytometry has a major advantage over other methods, such as Western blotting, because the level of antigen is measured in each cell individually. Measurements of specific subsets, for example, CD4
+ T cells, can be made 62, 65 and expression of two proteins, such as FAS and bcl-2 or bcl-2/bax, can be correlated 60, 62 ( Figure 3) . Recently, a protein in the mitochondrial membrane expressed during apoptosis (APO2.7) has been reported. 70, 71 Functional parameters associated with mitochondria
There are a variety of dyes that can be used to measure changes in MMP. The choice of dye depends on the laser used for excitation. For use with an argon-ion laser (tuned to 488 nm), it is customary to use either rhodamine 123, 49, 55, 72, 73 or 3, 3Ј-dihexyloxacarbocyanine iodide 51, [74] [75] [76] and to record green fluorescence which reduces when the MMP is reduced. An alternative dye is (JC-1) whose fluorescence shifts from green to red depending on the state of aggregation of the dye. 72, 76 The total mitochondrial mass, which may be reduced in apoptotic cells, can be estimated by measuring fluorescence from nonyl acridine orange. 72 Figure 4 shows an example of the observation of a reduction in MMP during apoptosis.
The reduction in the MMP uncouples the respiratory chain leading to an increase in superoxide anions which can be detected using dihydroethidine (HE). 51, 74 HE is non-fluorescent and diffuses into cells; oxidation produces ethidium which intercalcates into DNA giving red fluorescence. Changes in the level of reactive oxygen intermediates (ROI) can be followed by using the non-fluorescent compound, 2Ј, 7Ј-dichlordihydrofluorescein diacetate (DCFH/DA).
Figure 4
Reduction in mitochondrial membrane potential (MMP) in apoptotic cells. Cells from a sub-line of the human lymphoblastoid cells, W1L2, were incubated with KCN, a treatment that triggers apoptosis in these cells. The cells were then incubated with 40 nm DiOC 6 ,
a dicyanine dye whose uptake reflects the MMP. 32 Propidium iodide (PI) was added before analysis using an argon-ion laser tuned to 488 nm. DCFH/DA permeates the cell wherein it is cleaved by esterases to give DCFH which remains trapped within the cell. On oxidation, green fluorescent dichlorofluorescein is produced. This assay has been used to observe an increase in ROI during apoptosis. 77 The disruption of the MMP is linked with a reduction in reduced glutathione (GSH) which can be measured using monobromobimane. 51, 78, 79 The reaction product of this dye fluoresces blue when excited by UV light so that this measurement requires a UV laser. The decrease in GSH precedes the increase in ROI. Since ROI, including superoxide anions, oxidise GSH, one would not expect to see an increase in the former until the latter had been depleted.
Other functional parameters
It has been reported that intracellular pH decreases during apoptosis. [80] [81] [82] [83] The measurements were made using (SNARF-1) which is excited at 488 nm and whose fluorescence shifts from red to deep red as the pH increases. Measurement of the ratio between these two fluorescences gives a sensitive measure of intracellular pH. 84 The change in pH may reflect the changes in the plasma membrane and a loss of function of the Na + /K + antiports. There is no evidence to suggest that reduction in pH is central to the apoptotic process rather than just being consequential to apoptotic change.
Changes in the level of intracellular calcium ions during apoptosis have been followed using indo-1 which is excited by UV and whose emission spectrum is affected by the Ca ++ concentration. 73, 79 Ca ++ elevation appears to follow reduction in the MMP and be associated with an increase in ROI. 79 An increase in active serine proteases has been observed in apoptotic cells. 85 The activity of the enzymes is measured using a short peptide linked to rhodamine 110 (R110); these substrates diffuse into cells wherein proteolytic action generates fluorescent R110. Substrates specific for caspases (as opposed to cysteine or serine proteases generally) have been Observation of Annexin V binding to apoptotic cells. Human peripheral blood lymphocytes were incubated for 48 h with 1 g/ml chlorambucil. The cells were incubated with FITC-Annexin V and PI added before analysis using an argon-ion laser tuned to 488 nm. Green (fluorescein) and red (PI/DNA) fluorescence were recorded. Three clusters of cells can be identified in panel a: normal cells (green −ve, red −ve) (labelled N), apoptotic cells (green +ve, red −ve) (A) and apoptotic cells undergoing secondary necrosis (green +ve, red +ve), (D). The light scatter profile showed two clusters (b). Gating on the cluster with the reduced forward angle scatter (R2) showed that it contained cells which were apoptotic (c); the other cluster (R1) contained all the normal cells plus a minority of the apoptotic cells (d). These data suggest that cell shrinkage occurs after the translocation of PS residues to the external plasma membrane. (Data supplied by Chris Pepper.) produced for use in an in vitro assay. 86 It is possible that these substrates would not diffuse into cells because of the length of the peptide needed to give specificity although I am not aware of any report of an attempt to use these substrates for a flow cytometric assay.
Measurements of changes in the plasma membrane
During apoptosis, phosphatidyl serine (PS) residues flip from the inside to the outside of the plasma membrane. 87 This change can be detected using Annexin V/FITC which binds to the PS residue. [88] [89] [90] [91] [92] The change is associated with an alteration in the packing of the lipids in the plasma membrane which can be followed using the change in binding of the fluorescent membrane probe, merocyanine 540. 87, 93 The rearrangement of the lipids in the plasma membrane probably occurs after the collapse of the MMP. 75, 92 Annexin V binds to the exterior of apoptotic cells but also binds to the inner face of the plasma membrane that has lost its integrity, either during the last stages of apoptosis or through some other necrotic process. When using this method to quantify apoptotic cells (which must be unfixed), it is customary to add PI to distinguish between apoptotic cells with an intact plasma membrane and those cells with a 'leaky' membrane that are undergoing secondary necrosis ( Figure 5) .
The plasma membrane of apoptotic cells is more permeable than that of normal cells 93 and a variety of DNA-binding dyes may taken up more rapidly by apoptotic cells. [93] [94] [95] [96] [97] [98] [99] [100] The method is applied to unfixed cells; necrotic cells (including apoptotic cells undergoing secondary necrosis) can be distinguished by adding PI.
Figure 6
Demonstration of the increased membrane permeability of apoptotic cells. 95 Apoptosis was induced in a murine haemopoietic cell line (BAF3) by the withdrawal of the growth factor, interleukin-3. Cells were incubated with 1 g/ml Hoechst 33342 at 37°C for 10 min. PI was added before analysis using a UV laser. Blue (Hoechst/DNA) and red (PI/DNA) fluorescence were recorded. Normal (N), apoptotic (A) and necrotic (D) cells can be observed. The DNA from the necrotic cells (apoptotic cells undergoing secondary necrosis) becomes further degraded causing loss of DNA from the cells. Figure 6 shows an example of the method using the bisbenzimadazole dye, Hoechst 33342. Cells were incubated briefly with the dye before adding PI and analysing using a UV laser. In a cytogram of blue (Hoechst) vs red (PI) fluorescence, clusters from normal, apoptotic and necrotic cells can be identified. Cells moving from the normal to the apoptotic cluster and from the apoptotic to the necrotic cluster can be seen. The DNA of the necrotic cells is slowly degraded so that necrotic cells with reduced PI fluorescence can also be observed.
In some cell types, such as immature rat thymocytes, the forward light scatter of apoptotic cells is reduced as compared to normal cells. By adding forward light scatter as a third parameter, the separation of normal and apoptotic cells can be improved 93, 96, 97, 101 (Figure 7 ). Hoechst 33258 is not taken up by normal cells and may give better discrimination of apoptotic cells. 98 Hoechst 33342 and 33258 can only be excited using a UV laser and the dicyanine, YO-PRO-1, which can be excited at 488 nm, may be preferred. 100 Ethidium bromide and 7-amino-actinomycin D, which are excluded by normal cells, may be taken up by apoptotic cells but the discrimination obtained is often not as good as with the other compounds mentioned. It should be emphasised that not all cells show differential dye uptake of Hoechst dyes on becoming apoptotic.
Observing shrinkage of apoptotic cells
Light scattered by cells in a narrow angle in the forward direction is highly dependent on cell size. Because of their smaller size, apoptotic cells frequently scatter less light. 93, 96, 97, 102 Light scattered at wider angles is affected by internal cell structures, which also change during apoptosis, so that the difference in light scatter between normal and apoptotic cells is influenced Apoptotic rat thymocytes have reduced forward light scatter. 96, 101 Immature rat thymocytes, incubated with 10 m dexamethasone to induce apoptosis, were incubated with 1 g/ml Hoechst 33342 at 37°C for 10 min. PI was added before analysis using a UV laser. Cells taking up PI were excluded from the analysis by gating on red fluorescence before FALS was displayed against blue fluorescence. The apoptotic cells (A) have less FALS and higher blue fluorescence than normal cells (N). (Cells were prepared by Xiao-Ming Sun.) by the angle over which the light is collected. 101 Consequently, any changes in light scatter during apoptosis will depend on the instrument configuration and the cell being studied.
When the plasma membrane loses its integrity, generally forward light scatter decreases and right angle scatter increases. In cell cultures, at a late stage in apoptosis, the holes appear in the plasma membrane (sometimes called secondary necrosis) and the light scatter will change accordingly.
After fixation, a reduction in both forward and right angle light scatter in the apoptotic cells may be observed. 103 Detecting changes in chromatin structure If viable cells are incubated with the dye, Hoechst 33342, under conditions that give good staining of the nuclear DNA, the apoptotic cells will show less blue fluorescence from the Hoechst 33342/DNA complexes. 104 It should be emphasised that, as the cells are viable, this effect is not due to loss of low molecular DNA from the cell as is observed if the cells are fixed and permeabilised (the so-called sub-G1 peak, see below). The fluorescent emission spectrum is also red shifted, 93, 105 ( Figure 8 ). Presumably these effects reflect a change in binding of the dye to DNA caused by changes in the chromatin although the detailed mechanism has not been evaluated.
Some dyes that bind to nucleic acids stain apoptotic cells less brightly. 106 Such dyes include SYTO-1 and LDS-751. The latter could be particularly useful since it can be combined with an antibody stain for surface antigens using fluorescein and phycoerythrin. The mechanism for the reduced staining is not known, but it has been suggested that it reflects a reduction in binding to DNA caused by the change in chromatin structure in apoptotic cells.
Figure 8
Red shift in Hoechst emission spectrum in apoptotic cells. Apoptosis was induced in a murine haemopoietic cell line (BAF3) by the withdrawal of the growth factor, interleukin-3. The cells were then incubated with 10 g/ml Hoechst 33342 for 10 min and PI added. Cells were analysed using a UV laser. Blue (Hoechst/DNA) and red (PI/DNA) fluorescence were recorded. Normal (N), apoptotic (A) and necrotic (D) cells can be observed in (a). Note that the apoptotic cells have more red and less blue fluorescence compared to the normal cells. Gating on light scatter (b) demonstrates that, for these cells, the light scatter only changes when the plasma membrane becomes 'leaky' (and takes up PI).
Figure 9
Apoptotic cells give a 'sub-G1' peak in the DNA histogram. Apoptosis was induced in a murine haemopoietic cell line (BAF3) by the withdrawal of the growth factor, interleukin-3. Cells were fixed in 70% ethanol, washed and resuspended in PBS containing 20 g/ml PI and 100 g/ml RNase. Excitation was at 488 nm and red fluorescence (PI/DNA) was recorded after gating to exclude any clumped cells. 95 Cells were incubated in the presence (a) or absence (b) of IL-3. The positions of the apoptotic cells (A) and the different cell cycle phases (G1, S and G2/M) are marked.
Changes in the chromatin also alter the denaturability of the DNA. This property can be measured using acridine orange. 13, 107, 108 Acridine orange fluoresces green when intercalated into double stranded nucleic acids but fluoresces red when bound to single strand RNA or DNA. It may therefore be used to distinguish apoptotic cells on account of the increased single stranded DNA. 109 An alternative assay uses an antibody to single stranded DNA. 110 Measurement of DNA degradation Endonuclease action at a late stage in the apoptotic cascade creates large numbers of small fragments of DNA. If cells are fixed in ethanol and subsequently rehydrated, some of the lower molecular weight DNA leaches out, lowering the DNA content. These cells can be observed as a hypodiploid or 'sub-G1' peak in a DNA histogram (Figure 9 ). The amount of DNA extracted -and hence the position of the sub-G1 peakdepends on the type of cell being studied and the buffer in which the cells are resuspended.
14,111 Care should always be
Figure 10
Murine haemopoietic cells (BAF3), incubated overnight without IL-3 to induce apoptosis, labelled using the Tdt assay. Cells were fixed in 1% paraformaldehyde followed by 70% ethanol. After rehydration, they were incubated with Tdt enzyme, biotin d-dUTP and CoCl 2 at 37°C for 1 h. After washing, cells were incubated with FITC-avidin. Before analysis, 20 g/ml PI was added. A cytogram of log green fluorescence against red (PI/DNA) fluorescence is shown. The label, R2, marks the apoptotic cells. Cells were sorted for light microscopy from the regions shown. (Cells prepared by Simone Detre and the data recorded by Jenny Titley.) Excitation at 488 nm.
Figure 11
Cells from a fine needle aspirate of a human breast carcinoma labelled using the Tdt assay. Details as in Figure 5 . The labels, R4 and R3, mark the position of G1 for the diploid and aneuploid cells. Cells sorted from the region marked R2 had an apoptotic nuclear morphology. (Cells prepared by Simone Detre and the data recorded by Jenny Titley.) Excitation at 488 nm.
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taken in interpreting data from a DNA histogram.
14 Apoptotic cells should be observed as a distinct peak. Necrotic cells, whose DNA is degraded randomly, will have a reduced DNA content and will be distributed across the same region of the histogram. If the instrument has been set to trigger on DNA/dye fluorescence (as is usually done when measuring a DNA histogram), an artifical 'sub-G1' peak may be observed. This can be a particular problem if a logarithmic (as opposed to linear) amplifier is used. 14 The ends of the broken strands of DNA can be labelled by incorporating either biotin-labelled or digoxigenin-labelled deoxynucleotides or deoxybromouridine using either the Klenow fragment of DNA polymerase I from Esherichia coli or terminal deoxynycleotidyl transferase. 14, 112 This is the basis for the ISEL (in situ end labelling method). Cells are fixed in paraformaldehyde to cross-link the small fragments of DNA into the cell before fixation in 70% ethanol. They are incubated with the enzyme and a labelled nucleotide (digoxygenin-dUTP, biotin-dUTP or bromo-dUTP-BrdUdr) which is detected using either FITC-labelled anti-digoxigenin, FITC-labelled avidin or FITC-anti-BrdUdr. After the addition of propidium iodide (PI) to label the DNA, green (FITC) vs red (PI) fluorescence is recorded in the flow cytometer. The apoptotic cells fluoresce green, the DNA stain indicates the cell cycle compartment from which apoptosis was induced ( Figure 10 ). The additional information about the cell cycle is one of the major advantages of ISEL. 14, 113, 114 If cultured cells are pulse labelled with BrdUdr to label replicating DNA, the method can be adapted to label simultaneously the S phase cells in the non-apoptotic population and the apoptotic cells. 115, 116 In isolated nuclei, ISEL is sensitive enough to detect cells that have only undergone the initial stages of DNA degradation (to 30-50 kbp fragments). 117 Although the method has been used to detect this low level of DNA degradation in whole cells, 118 because of the higher levels of autofluorescence from the cytoplasm, discrimination is poor.
ISEL has been applied to clinical samples, 67, 68, 119 in particular, it has been used to follow the induction of apoptosis in leukaemic cells in peripheral blood during the course of chemotherapy. [120] [121] [122] [123] An unexpected finding from these experiments was that cells underwent apoptosis from G1/G0 phase of the cell cycle, irrespective of the chemotherapeutic drug used. The same drugs used in cell cultures showed a different cell cycle specificity.
123 Figure 11 shows the detection of apoptotic cells in a fine needle aspirate taken from a human breast carcinoma. The identification of the apoptotic cells was confirmed by cell sorting.
Conclusion
Flow cytometry has established itself as an essential tool in the enumeration of apoptotic cells and in the study of the mechanisms involved in the apoptotic process. It is the method of choice for following changes in functional parameters, such as the collapse in mitochondrial membrane potential, during apoptosis. The use of flow cytometry for following early changes in the chemotherapy of tumours is now under investigation.
